WVE Straddle Strategy
WVE (Wave Life Sciences Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of liver disease; WVE-N531, an exon splicing oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington’s disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
WVE (Wave Life Sciences Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.07B, a beta of -1.29 versus the broader market, a 52-week range of 5.01-21.73, average daily share volume of 3.5M, a public-listing history dating back to 2015, approximately 317 full-time employees. These structural characteristics shape how WVE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -1.29 indicates WVE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on WVE?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
WVE snapshot
As of August 14, 2026, spot at $5.36, ATM IV 83.20%, IV rank 22.05%, expected move 23.85%. The straddle on WVE below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this straddle structure on WVE specifically: WVE IV at 83.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a WVE straddle, with a market-implied 1-standard-deviation move of approximately 23.85% (roughly $1.28 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated WVE expiries trade a higher absolute premium for lower per-day decay. Position sizing on WVE should anchor to the underlying notional of $5.36 per share and to the trader's directional view on WVE stock.
WVE straddle setup
The WVE straddle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With WVE at $5.36 on that close, the first option leg uses a $5.36 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed WVE chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 WVE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $5.36 | N/A |
| Buy 1 | Put | $5.36 | N/A |
WVE straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
WVE straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on WVE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on WVE
Straddles on WVE are pure-volatility plays that profit from large moves in either direction; traders typically buy WVE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
WVE thesis for this straddle
The market-implied 1-standard-deviation range for WVE extends from approximately $4.08 on the downside to $6.64 on the upside. A WVE long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current WVE IV rank near 22.05% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on WVE at 83.20%. As a Healthcare name, WVE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to WVE-specific events.
WVE straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. WVE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move WVE alongside the broader basket even when WVE-specific fundamentals are unchanged. Always rebuild the position from current WVE chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on WVE?
- A straddle on WVE is the straddle strategy applied to WVE (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With WVE stock at $5.36 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed WVE chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are WVE straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the WVE straddle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 83.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a WVE straddle?
- The breakeven for the WVE straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The WVE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 23.85%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on WVE?
- Straddles on WVE are pure-volatility plays that profit from large moves in either direction; traders typically buy WVE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current WVE implied volatility affect this straddle?
- WVE ATM IV is at 83.20% with IV rank near 22.05%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.